Novo will take two board seats at newly-founded startup Aristea Therapeutics after a $15m investment to fund a pipeline of inflammatory disease drugs.

Based on Oxford and Sao Paulo State University research, Osler Diagnostics is reportedly set to secure $38m to add to the $2.6m it raised in 2016.

Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

In the second half of our guide to corporate venturing's biggest trends in 2018, we look at the growth of Chinese tech companies, genomics, advances in transport tech and the growth of the scooter rental space.

SoftBank Vision Fund led a series C round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.

MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A, which is commercialising research by Prof Dehua Pei at OSU.

Purdue University-backed Elevate Purdue Foundry Fund has picked seven university-linked businesses to share a total of $200,000 in funding.

MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A round, which will fund clinical trials of its lead program.

Pulmonary arterial hypertension therapy business Morphogen-IX has been backed by Cambridge Enterprise and Cambridge Innovation Capital in a $23.3m round.